Skip to content

Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial

Denise Millstine, A. Bhagra, S. Jenkins, Ivana T Croghan, D. Stan, J. Boughey, Minh-Doan T. Nguyen, Sandhya Pruthi

Integrative Cancer Therapies 2019 DOI: 10.1177/1534735419878770 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized feasibility study Peer reviewed
Sample size 30
Population Women aged 20-75 years with a recent diagnosis of breast cancer planning to undergo surgical treatment
Intervention CD-based stress-reduction education
Duration From breast cancer diagnosis until 3 months after surgical treatment; assessments at baseline, within 4 days before surgery, up to 14 days after surgery, and 3 months after surgery
Topics Meditation
Key points Both the wearable-device meditation group and the CD-based stress-reduction control group showed reduced fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, with no significant differences between groups at any time point. The authors conclude that the wearable electroencephalographic device for meditation is a feasible strategy for breast cancer patients.

Abstract

Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment.

Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery.

Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point.

Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 6

and 1 more in the library

Cites 5

Explore topics